Exclusive

Publication

Byline

Nxera Pharma Japan licenses Quviviq to Taiwan's Synmosa Biopharma in 8 APAC markets

Singapore, Oct. 19 -- Nxera Pharma has announced that its subsidiary, Nxera Pharma Japan has entered into an exclusive license, supply and commercialisation agreement with Taiwan-headquartered Synmosa... Read More


S2N.Bio begins Alzheimer's cell therapy technology transfer to Cell Therapies' Melbourne GMP facility

Singapore, Oct. 19 -- Cell Therapies Pty Ltd (CTPL) and S2N.Bio have commenced technology transfer of S2N's cell therapy candidate for Alzheimer's disease. The transfer will enable GMP manufacture of ... Read More


HistoIndex partners with A*STAR to advance early-stage development of pipeline therapies for fibrotic diseases in Singapore

Singapore, Oct. 19 -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agenc... Read More


Merck inaugurates State-of-the-Art ADVANCE Bioanalytical Facility in US

Singapore, Oct. 19 -- Merck, known as MSD outside of the United States and Canada, has inaugurated its state-of-the-art ADVANCE research facility on its West Point, Pennsylvania, campus, signaling a n... Read More


Researchers in Korea explore use of smartphones to help detect lung problems in children

Singapore, Oct. 19 -- Respiratory disease in children is a major global concern. Although stethoscopes help clinicians detect abnormal lung sounds, access to auscultation may be limited by the need fo... Read More


Taiwan's Jyong Biotech to establish new manufacturing facility and US operations centre in Texas

Singapore, Oct. 17 -- Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of innovative plant-derived therapeutics, has announced that... Read More


Charles River collaborates with Magellan Stem Cells to advance regenerative medicine development

Singapore, Oct. 16 -- Charles River Laboratories International, Inc. and Magellan Stem Cells, a private Australian biotech and cell-therapy firm, have announced their collaboration to support Magellan... Read More


Korea's NTL HEALTHCARE announces global launch of On-Premises AI Solution 'CerviCARE(R) AI AT'

Singapore, Oct. 16 -- South Korea-based NTL HEALTHCARE, a women's health AI company, has announced the global launch of CerviCARE(R) AI AT, an on-premises version of its AI-powered cervical screening ... Read More


AtomVie inks strategic partnership with Jubilant Radiopharma to strengthen logistics and distribution in Clinical Trials

Singapore, Oct. 16 -- AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced a strategic partnership with Jubilant DraxImage Inc., trad... Read More


Singapore's Health Sciences Authority accelerates healthcare innovations with new partnerships

Singapore, Oct. 15 -- The Health Sciences Authority (HSA) in Singapore has announced three initiatives to help promising healthcare innovations reach patients sooner: (i) collaboration with the United... Read More